These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 28401431)
1. Sustained Immunosuppression Alters Olfactory Function in the MRL Model of CNS Lupus. Kapadia M; Zhao H; Ma D; Sakic B J Neuroimmune Pharmacol; 2017 Sep; 12(3):555-564. PubMed ID: 28401431 [TBL] [Abstract][Full Text] [Related]
2. Effect of cyclophosphamide on leukocytic infiltration in the brain of MRL/lpr mice. Farrell M; Sakić B; Szechtman H; Denburg JA Lupus; 1997; 6(3):268-74. PubMed ID: 9104735 [TBL] [Abstract][Full Text] [Related]
3. Altered olfactory function in the MRL model of CNS lupus. Kapadia M; Stanojcic M; Earls AM; Pulapaka S; Lee J; Sakic B Behav Brain Res; 2012 Oct; 234(2):303-11. PubMed ID: 22796602 [TBL] [Abstract][Full Text] [Related]
4. Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice. Ballok DA; Earls AM; Krasnik C; Hoffman SA; Sakic B J Neuroimmunol; 2004 Jul; 152(1-2):83-97. PubMed ID: 15223241 [TBL] [Abstract][Full Text] [Related]
5. Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice. Stock AD; Wen J; Doerner J; Herlitz LC; Gulinello M; Putterman C J Neuroinflammation; 2015 Nov; 12():205. PubMed ID: 26546449 [TBL] [Abstract][Full Text] [Related]
6. Proclivity to self-injurious behavior in MRL-lpr mice: implications for autoimmunity-induced damage in the dopaminergic system. Chun S; McEvilly R; Foster JA; Sakic B Mol Psychiatry; 2008 Nov; 13(11):1043-53. PubMed ID: 17768421 [TBL] [Abstract][Full Text] [Related]
8. Immunosuppression prevents neuronal atrophy in lupus-prone mice: evidence for brain damage induced by autoimmune disease? Sakic B; Kolb B; Whishaw IQ; Gorny G; Szechtman H; Denburg JA J Neuroimmunol; 2000 Nov; 111(1-2):93-101. PubMed ID: 11063826 [TBL] [Abstract][Full Text] [Related]
9. Purine receptor antagonist modulates serology and affective behaviors in lupus-prone mice: evidence of autoimmune-induced pain? Ballok DA; Sakic B Brain Behav Immun; 2008 Nov; 22(8):1208-16. PubMed ID: 18601998 [TBL] [Abstract][Full Text] [Related]
10. Hippocampal damage in mouse and human forms of systemic autoimmune disease. Ballok DA; Woulfe J; Sur M; Cyr M; Sakic B Hippocampus; 2004; 14(5):649-61. PubMed ID: 15301441 [TBL] [Abstract][Full Text] [Related]
11. Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice. Anderson KK; Ballok DA; Prasad N; Szechtman H; Sakic B Behav Brain Res; 2006 Jan; 166(1):32-8. PubMed ID: 16183144 [TBL] [Abstract][Full Text] [Related]
12. Treatment with lysophosphatidic acid improves glomerulonephritis through the suppression of macrophage activation in a murine model of systemic lupus erythematosus. Nagata W; Takayama E; Nakagawa K; Koizumi A; Ohsawa Y; Goto H; Yamashiro A; Ishinoda Y; Tanoue K; Kumagai H; Oshima N; Ishizuka T Clin Exp Rheumatol; 2024 Mar; 42(3):658-665. PubMed ID: 38436267 [TBL] [Abstract][Full Text] [Related]
13. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus. Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816 [TBL] [Abstract][Full Text] [Related]
14. Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study. Sakić B; Denburg JA; Denburg SD; Szechtman H Brain Res Bull; 1996; 41(5):305-11. PubMed ID: 8924042 [TBL] [Abstract][Full Text] [Related]
15. Altered neuroendocrine status at the onset of CNS lupus-like disease. Loheswaran G; Kapadia M; Gladman M; Pulapaka S; Xu L; Stanojcic M; Sakic B Brain Behav Immun; 2013 Aug; 32():86-93. PubMed ID: 23466502 [TBL] [Abstract][Full Text] [Related]
16. A behavioral profile of autoimmune lupus-prone MRL mice. Sakić B; Szechtman H; Keffer M; Talangbayan H; Stead R; Denburg JA Brain Behav Immun; 1992 Sep; 6(3):265-85. PubMed ID: 1392101 [TBL] [Abstract][Full Text] [Related]
17. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining. Ballok DA; Millward JM; Sakic B Brain Res; 2003 Feb; 964(2):200-10. PubMed ID: 12576180 [TBL] [Abstract][Full Text] [Related]
18. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011 [TBL] [Abstract][Full Text] [Related]
19. Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT). Karussis DM; Vourka-Karussis U; Lehmann D; Abramsky O; Ben-Nun A; Slavin S Clin Exp Immunol; 1995 Apr; 100(1):111-7. PubMed ID: 7697909 [TBL] [Abstract][Full Text] [Related]
20. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway. Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]